A $27M Series A for women's health software signals that VCs are finally writing bigger checks for this category after years of underfunding—Bain leading suggests they see a defensible, recurring revenue model (likely B2B2C or direct-to-consumer subscription). At this stage and size, Hera's probably scaling sales/marketing and building out clinical partnerships or integrations; if you're in adjacent health verticals, watch whether they're bundling with other services or staying pure-play, because that'll tell you if consolidation is coming to health software.
All funding news
Hera
Hera builds software for women's health and wellness.
Rounds tracked
1
Funding history
Want a deeper look at Hera?
Ask Dormy who's likely on their cap table, what kind of companies their lead investor backs, and how to reach them.